Apontis Pharma AG (APPH) — Working Capital to Net Assets Ratio
Apontis Pharma AG (APPH) has a Working Capital to Net Assets ratio of 56.7% as of June 2025. Working capital of €17.93 Million (current assets of €21.01 Million minus current liabilities of €3.08 Million) is measured against net assets of €31.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Apontis Pharma AG balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apontis Pharma AG Working Capital to Net Assets (2018–2024)
This chart shows how Apontis Pharma AG's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 56.7%, reflecting working capital of €17.93 Million against net assets of €31.62 Million EUR. Check Apontis Pharma AG (APPH) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see APPH stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.2% | €18.69 Million | €31.02 Million | €23.44 Million | €4.75 Million | ▼ -20.8 pp |
| 2023 | 81.0% | €24.52 Million | €30.26 Million | €35.63 Million | €11.11 Million | ▼ -7.8 pp |
| 2022 | 88.8% | €36.90 Million | €41.57 Million | €42.86 Million | €5.96 Million | ▲ +1.8 pp |
| 2021 | 86.9% | €35.39 Million | €40.71 Million | €38.46 Million | €3.07 Million | ▲ +226.7 pp |
| 2020 | -139.8% | €-4.84 Million | €3.46 Million | €13.49 Million | €18.32 Million | ▼ -75.7 pp |
| 2019 | -64.1% | €-2.98 Million | €4.64 Million | €13.86 Million | €16.83 Million | ▼ -79.6 pp |
| 2018 | 15.4% | €1.08 Million | €7.03 Million | €19.06 Million | €17.98 Million | — |